A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes
Francisco Javier Ampudia‐Blasco(Hospital Clínico Universitario de Valencia), Herman Stoevelaar(Barnes-Jewish Hospital), Cees J. Tack(Radboud University Nijmegen), G. Charpentier(Centre Hospitalier Sud Francilien), Martin Ridderstråle(Steno Diabetes Centers), Chantal Mathieu(KU Leuven), Jochen Seufert(University of Freiburg), Tra‐Mi Phan(Medtronic (Ireland)), Pierre‐Yves Benhamou(Centre Hospitalier Universitaire de Grenoble), Kamlesh Khunti(University of Leicester), Baptist Gallwitz, Agostino Consoli(University of Chieti-Pescara), Michaëla Diamant(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tina Vilsbøll(University of Copenhagen)
Cited by 15
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k